BiotechTube
Home/Pipeline/MINC‑doxorubicin

MINC‑doxorubicin

Various solid tumors

PreclinicalActive

Key Facts

Indication
Various solid tumors
Phase
Preclinical
Status
Active
Company
Suntec Medical

About Suntec Medical

SunTec uses EGCG‑based nanocomplexes to deliver multi‑target immunotherapies for hard‑to‑treat cancers and CNS diseases.

View full company profile

Therapeutic Areas

OncologyCentral Nervous SystemAutoimmuneCardiovascularInfectious DiseasesGene TherapyVaccines

Other Various solid tumors Drugs

DrugCompanyPhase
NUC-8232NuCanaPhase 1
TCR Library ProgramMedigeneDiscovery
Guardant Infinity Biomarker DiscoveryGuardant HealthDevelopment/Commercial
Cytotoxic Oncology GenericMSN LaboratoriesPre‑clinical
APCEDEN®APAC BiotechApproved
Solid Tumor ProfilingDiatech PharmacogeneticsCommercial
BAVENCIO (avelumab)EMD SeronoApproved
FoundationOne®CDx Indication ExpansionFoundation MedicineApproved/Commercial
FoundationOne®Liquid CDx Indication ExpansionFoundation MedicineApproved/Commercial
177Lu‑BetaBart (RV‑01)AtomVie Global RadiopharmaPhase 1/2a
BeiGene Oncology PortfolioEVA PharmaPhase 2/3
Bevacizumab BiosimilarBio Usawa BiotechnologyPreclinical